A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer

NCT07512076 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Patients
Elderly Patients
Pharmacokinetic Study

Interventions

DRUG: Enzalutamide Dose Escalation
DRUG: Standard of Care

Sponsor

Sunnybrook Health Sciences Centre